LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS : Impact Factor & More
eISSN: 2292-5945pISSN: 2292-5937
Share this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS Journal Specifications
| Overview | |
| Publisher | LYMPHOSIGN JOURNAL LTD PARTNERSHIP |
| Language | English |
| Frequency | Quarterly |
| General Details |
View less
Planning to publish in LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS
A novel confirmed humoral immunodeficiency associated with <i>QARS1</i> mutation
- 19 Feb 2026
- LymphoSign Journal
A Novel Missense Variant in CTLA4 Associated with Immune Dysregulation
- 19 Nov 2025
- LymphoSign Journal
Phenotypic and Genetic Characterization of Heterozygous FOXN1 Variants: A Case Series of Mild Immunodeficiency
- 19 Nov 2025
- LymphoSign Journal
Primary immunodeficiencies related to folate and cobalamin transport and metabolism
- 7 Oct 2025
- LymphoSign Journal
Transition from Subcutaneous to Intravenous Immunoglobulin Therapy in Primary Immunodeficiency: A Case Series Highlighting Patient-Centered Treatment Optimization
- 16 Jun 2025
- LymphoSign Journal
2025 Canadian resource guides for individuals and families affected by primary immunodeficiency
- 1 Mar 2025
- LymphoSign Journal
A novel confirmed humoral immunodeficiency associated with <i>QARS1</i> mutation
- 19 Feb 2026
- LymphoSign Journal
A Novel Missense Variant in CTLA4 Associated with Immune Dysregulation
- 19 Nov 2025
- LymphoSign Journal
Phenotypic and Genetic Characterization of Heterozygous FOXN1 Variants: A Case Series of Mild Immunodeficiency
- 19 Nov 2025
- LymphoSign Journal
Primary immunodeficiencies related to folate and cobalamin transport and metabolism
- 7 Oct 2025
- LymphoSign Journal
Transition from Subcutaneous to Intravenous Immunoglobulin Therapy in Primary Immunodeficiency: A Case Series Highlighting Patient-Centered Treatment Optimization
- 16 Jun 2025
- LymphoSign Journal
2025 Canadian resource guides for individuals and families affected by primary immunodeficiency
- 1 Mar 2025
- LymphoSign Journal
FAQs on LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS
How long has LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS been actively publishing? 
What is the publishing frequency of LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS?
How many articles did LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS publish last year?
What is the eISSN & pISSN for LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS?
Who is the publisher of LYMPHOSIGN JOURNAL-THE JOURNAL OF INHERITED IMMUNE DISORDERS?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations